Author:
Adachi Wataru,Koike Shoichiro,Rafique Mohammad,Kajikawa Shoji,Kaneko Gengo,Kuroda Takai,Iida Futoshi,Ishii Keiko
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Dedrick RL, Myers CE, Bungay PM, DeVita VT Jr (1978) Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62:1?11
2. Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Int Med 97:845?851
3. Zylberberg B, Ravina JH, Salat-Baroux J, Madelenat P, Zarca D, Dormont D (1990) Chemotherapy by the intravenous and intraperitoneal routes combined in ovarian cancer. Gynecol Oncol 36:271?276
4. Casper ES, Kelsen DP, Alcock NW, Lewis JL Jr (1983) Ip cisplatin in patients with malignant ascites: Pharmacokinetic evaluation and comparison with the iv route. Cancer Treat Rep 67:235?238
5. Markman M (1985) Intracavitary chemotherapy for malignant disease confined to body cavities. West J Med 142:364?368
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献